Search

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) (ENDEAVOR)
A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74 (HORIZON)
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study (EXPEDITION)
A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice (EVOLVE)
A Study of the Natural History of Participants With LGMD2E/​R4, LGMD2D/​R3, LGMD2C/​R5, and LGMD2A/​R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995)
SareptAssist Peer-to-Peer Program
SareptAssist Peer-to-Peer Program - Thank You
Route 79 Scholarship Program
TERMS OF USE FOR SAREPTA THERAPEUTICS, INC.'S WEBSITES